ROSEN, A LEADING LAW FIRM, Encourages Lufax Holding Ltd Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - LU

Lufax reported Q2 2026 earnings with total income of RMB6,227 million, a 15.5% decrease YoY. Net loss narrowed to RMB82 million, an 86.2% improvement YoY. Loans outstanding decreased 13.5% YoY, but consumer finance loans rose 19.9%. New loans increased 4.6% YoY, driven by a 27.6% rise in consumer finance loans. CEO Xiang Ji highlighted improved asset quality and governance.

Lufax Holding said four of its nine board members, including CFO Xi Tongzhuan, resigned, and the company appointed a new independent director. The resignations follow a Hong Kong trading suspension tied to prior accounting issues and restatements. Lufax reported Q2 operational updates but did not give a resumption date. NY shares rose about 5% over two days.

Advanced Micro Devices (AMD) filed its first 13F, revealing a $1.31 billion portfolio with six positions. Top holdings include SpaceX, Absci (ABSI), Sanmina (SANM), Nutanix (NTNX), and Quantum Computing (QUBT). AMD's Q2 revenue surged 50.1% YoY to $11.536 billion, with data center revenue doubling. AMD expects Q3 revenue of $13 billion, citing strong AI demand.

Rocket Lab received $12M in orders from the U.S. Space Force for a secure optical communications program. The company joined the Space Force's consortium to develop a resilient satellite network. Rocket Lab will design, test, and demonstrate key technologies for the SDN Backbone program and conduct an in-orbit demo using its Photon spacecraft. Delivery is expected in 2027, according to the company.

Haemonetics Corporation (NYSE:HAE) rose 15.9% after announcing a supply agreement with CSL Plasma, adding to its 91.88% surge since being identified by InvestingPro's AI models. The company reported Q1 2027 revenue of $339.4M and adjusted EPS of $1.14, raising its full-year revenue growth outlook to 5-8%. InvestingPro's AI-powered stock picker has identified multiple stocks with significant gains, including Haemonetics, which was highlighted for its valuation, profitability, and growth potential

KBR won a five-year NATO contract with a $60M initial ceiling to support PATRIOT air and missile defense systems and their integration with IBCS. The contract includes command-and-control engineering, technical support, and operational readiness for deployed systems. Work will occur at multiple U.S. locations. KBR has supported the PATRIOT system for about 40 years.